GGrantIndex
Sort

40,608 grants matching prostate cancer

Tumor Detection and Classification using QUS Technology's Structure Function

$500,727
William D. O'Brien · University Of Illinois At Urbana-Champaign · R01 · FY2019 · CA

Early Life Exposures and Subsequent Cancer Risk

$500,700
Robert Hoover · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA

CANCER AND LEUKEMIA GROUP B

$500,685
Dana-Farber Cancer Institute · U10 · FY2002 · CA

Identification of novel pathways causing NF1-driven Schwann cell tumors

$500,637
Nancy Ratner · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · NS

Identification of novel pathways causing NF1-driven Schwann cell tumors

$500,637
Nancy Ratner · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · NS

Identification of Novel Pathways Causing NF1-Driven Schwann Cell Tumors

$500,637
Nancy Ratner · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · NS

Genomic bases for African geo-ethnic prostate cancer health disparity

$500,626
Vanessa Marie Hayes · University Of Sydney · R01 · FY2024 · CA

FDG PET-CT in Metastatic Prostate Cancer

$500,603
Hossein Jadvar · University Of Southern California · R01 · FY2006 · CA

Biostatistics Core

$500,548
Qi Long · University Of Pennsylvania · P30 · FY2018 · CA

Optimizing Age-based Anal Cancer Screening Among People Living with HIV using Decision Analytic Modeling

$500,531
Ashish A. Deshmukh · University Of Texas Hlth Sci Ctr Houston · R01 · FY2020 · CA

FDG PET-CT in Metastatic Prostate Cancer

$500,516
Hossein Jadvar · University Of Southern California · R01 · FY2007 · CA

Evaluation of immunotherapy-novel treatments in biochemically recurrent prostate

$500,512
Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Genomic Imprinting in Cancer

$500,505
Andrew P Feinberg · Johns Hopkins University · R01 · FY2010 · CA

Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer

$500,369
Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Drug Mechanism of Action-based targeting of tumor subpopulations

$500,354
Andrea Califano · Columbia University Health Sciences · U54 · FY2025 · CA

Qualifying Multi-Transcript Signatures for Active Surveillance of Prostate Cancer

$500,277
Hyung L Kim · Cedars-Sinai Medical Center · R01 · FY2015 · CA

Endoplasmic Reticulum-to-Mitochondria Calcium Transfer in Pancreatic Cancer Development, Metastasis, and Treatment

$500,269
J. Kevin Kevin Foskett · University Of Pennsylvania · R01 · FY2024 · CA

HPV genomic structure in cervical cancer radiation response and recurrence detection

$500,244
Jin Zhang · Washington University · R37 · FY2023 · CA

GI Tract Dysbiosis and Breast Cancer

$500,236
Susan E. Erdman · Massachusetts Institute Of Technology · U01 · FY2013 · CA

Role of p62 in metabolic reprograming of the tumor stroma in prostate cancer

$500,144
Maria Teresa Diaz Meco Conde · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA

Ascorbate-based biomarkers for predicting radiation response in prostate cancer

$500,056
David M Wilson · University Of California, San Francisco · R01 · FY2012 · CA

Mapping and Cloning Prostate Cancer Predisposition Loci

$500,053
University Of Utah · R01 · FY2001 · CA

Phase2 trial of MEK162 & imatinib combined therapy in GIST, IND119794(09/20/2013)

$500,000
Ping Chi · Sloan-Kettering Inst Can Research · R01 · FY2018 · FD

9.4T/20 cm MRI for Cancer Research

$500,000
Jason A Koutcher · Sloan-Kettering Inst Can Research · S10 · FY2007 · RR

Phase2 trial of MEK162 & imatinib combined therapy in GIST, IND119794(09/20/2013)

$500,000
Ping Chi · Sloan-Kettering Inst Can Research · R01 · FY2017 · FD